Lobbying Update: $30,000 of GRAIL INC. lobbying was just disclosed

$30,000 of GRAIL INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act.
Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act."

You can find more data on corporate lobbying on Quiver Quantitative.

GRAL Insider Trading Activity

GRAL insiders have traded $GRAL stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $GRAL stock by insiders over the last 6 months:

• ROBERT P RAGUSA (Chief Executive Officer) sold 123,454 shares for an estimated $1,730,825
• JOSHUA J. OFMAN (President) sold 74,084 shares for an estimated $1,203,650
• CHUN R DING has made 4 purchases buying 78,829 shares for an estimated $1,024,698 and 0 sales.
• AARON FREIDIN (Chief Financial Officer) has made 0 purchases and 2 sales selling 46,093 shares for an estimated $681,057.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.